KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer.

Cancer · 2025-Apr-01 · PMID 40106307

Panel E提取完成待 EXE 对齐验证

PFS2

FIGURE 2 Inverse probability of treatment weighting‐adjusted Kaplan–Meier plots based on bone metastasis count. (A–F) Inverse probability of treatment weighting‐adjusted Kaplan–Meier plots by treatment, with subgroups based on bone metastasis count (one or two vs. three or more). Solid lines represent point estimates, and shaded areas represent 95% CIs. HRs were estimated based on inverse probability of treatment weighting‐adjusted Cox proportional hazards regression models. HRs < 1.0 favor apalutamide. CI indicates confidence interval; HR, hazard ratio; IPTW, inverse probability of treatment weighting; OS, overall survival; PFS, progression‐free survival; PFS2, second progression‐free survival; rPFS, radiographic progression‐free survival.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分1.00
质量通过是
预期曲线2
实际曲线2
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0complete待验证22026-07-18T20:20:34+00:00